ReElement Technologies stock soars after securing $1.4B government deal
Saba Capital Management, L.P., a ten-percent owner of Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), has increased its stake in the company. According to a Form 4 filing with the Securities and Exchange Commission, Saba Capital purchased 20,808 shares of common stock at a price of $9.28 per share, for a total transaction value of $193,098.
The transaction, which took place on October 23, 2025, increased Saba Capital Management’s total holdings to 2,088,354 shares. InvestingPro analysis reveals several additional key metrics and insights about GRX, with 6 more exclusive ProTips available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
